Page last updated: 2024-11-04

vorinostat and Neuralgia

vorinostat has been researched along with Neuralgia in 3 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Wang, C1
Chen, R1
Zhu, X1
Zhang, X1
Feng, XL1
Deng, HB1
Wang, ZG1
Wu, Y1
Ke, JJ2
Feng, XB1
Cui, SS1
Lu, R1
Zhang, H1
Wang, W1

Other Studies

3 other studies available for vorinostat and Neuralgia

ArticleYear
Suberoylanilide Hydroxamic Acid Ameliorates Pain Sensitization in Central Neuropathic Pain After Spinal Cord Injury via the HDAC5/NEDD4/SCN9A Axis.
    Neurochemical research, 2023, Volume: 48, Issue:8

    Topics: Animals; Hyperalgesia; Mice; Neuralgia; Spinal Cord; Spinal Cord Injuries; Up-Regulation; Vorinostat

2023
Suberoylanilide Hydroxamic Acid Triggers Autophagy by Influencing the mTOR Pathway in the Spinal Dorsal Horn in a Rat Neuropathic Pain Model.
    Neurochemical research, 2019, Volume: 44, Issue:2

    Topics: Animals; Astrocytes; Autophagy; Disease Models, Animal; Histone Deacetylase Inhibitors; Male; Neural

2019
Suberoylanilide hydroxamic acid prevents downregulation of spinal glutamate transporter-1 and attenuates spinal nerve ligation-induced neuropathic pain behavior.
    Neuroreport, 2016, Apr-13, Volume: 27, Issue:6

    Topics: Acetylation; Animals; Disease Models, Animal; Down-Regulation; Excitatory Amino Acid Transporter 2;

2016